Today: 30 April 2026
Browse Category

Stock Market 30 December 2025

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Karman Holdings shares fell 3.6% to $74.81 in New York afternoon trading Tuesday, underperforming the broader market after a $258.7 million outflow from the SPDR S&P Aerospace & Defense ETF. The stock touched a session low of $74.21, with about 465,000 shares traded. Investors are watching for signs of stabilization ahead of the company’s next quarterly update.
30 December 2025
··
CRH stock dips today as buyback rolls on and Fed minutes loom

CRH stock dips today as buyback rolls on and Fed minutes loom

CRH shares fell 1.1% to $126.01 in New York Tuesday after the company disclosed buying 31,100 shares Monday under its U.S. buyback program. The repurchases, part of a $300 million plan, came as markets traded in thin year-end conditions. Investors awaited Federal Reserve minutes due later in the day. Other U.S.-listed aggregates producers also slipped.
30 December 2025
·
Schwab stock slips as Fed minutes put rate outlook back in focus

Schwab stock slips as Fed minutes put rate outlook back in focus

Charles Schwab shares fell 0.6% to $100.69 in afternoon trading Tuesday, with rivals Interactive Brokers and Robinhood also lower. Investors awaited Federal Reserve minutes due later in the day for signals on rate policy. A regulatory filing showed Schwab executive Jonathan Beatty exercised options and a related trust sold 2,000 shares at about $102.01. Schwab’s fourth-quarter results are expected Jan. 21.
30 December 2025
·····
KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA shares fell 0.8% to $1,250.43 Tuesday after a Reuters report said China will require chipmakers to source at least half of new-fab equipment domestically. U.S. chip-equipment stocks tracked lower as traders awaited Federal Reserve minutes and eyed tightening export-license rules. Applied Materials and Lam Research also declined, while ASML rose.
30 December 2025
······
Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals shares fell 3.6% to $67.09 by early afternoon Tuesday, outpacing declines in biotech peers as traders positioned ahead of key January updates. The drop followed recent volatility after FDA approval of REDEMPLO, the company’s first commercial drug for familial chylomicronemia syndrome. Arrowhead plans to release interim obesity-program data and present at the J.P. Morgan Healthcare Conference in early January.
30 December 2025
··
Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo shares fell 0.4% to $94.15 in afternoon New York trading Tuesday, tracking declines across U.S. bank stocks ahead of Federal Reserve meeting minutes. Investors focused on rate expectations for 2026 and the bank’s upcoming earnings in mid-January. The 10-year Treasury yield rose to 4.134% as financial sector ETFs also slipped in thin, year-end trading.
30 December 2025
···
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer shares edged up 0.1% to $25.03 Tuesday after TD Cowen reiterated a Hold rating and $30 price target, citing negative trends through 2030. The company projected 2026 revenue of $59.5 billion to $62.5 billion and warned of a “bumpy” period ahead as COVID demand fades and key patents expire. Shares have dropped over 50% since early 2023. Pfizer’s next earnings report is set for February 3.
30 December 2025
··
Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels Inc shares fell 3.5% to $14.55 in Tuesday afternoon trading, underperforming uranium peers. The company said it exceeded 2025 uranium production guidance and completed two new long-term sales contracts with U.S. nuclear power generators. Energy Fuels expects to sell 360,000 pounds of U3O8 in Q4 for about $27 million at a weighted average price of $74.93 per pound.
30 December 2025
··
AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

Nvidia traded flat after reports of advanced talks to buy Israel’s AI21 Labs for up to $3 billion. Meta gained 1.17% to $666.40 after announcing plans to acquire AI startup Manus, with the deal valued at $2 billion to $3 billion by a source. Broader tech stocks were mixed in light, year-end trading. Investors awaited Federal Reserve meeting minutes for signals on 2026 interest rates.
30 December 2025
····
Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin rose 0.8% to $88,320 in New York Tuesday afternoon. U.S. spot bitcoin ETFs saw $19.3 million in net outflows Monday, led by BlackRock’s IBIT. Coinbase shares edged up 0.2%, while Strategy gained 1.4% after disclosing a $108.8 million bitcoin purchase. Fed minutes are due at 2 p.m. ET.
30 December 2025
·······
Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics shares fell 3.3% to $35.61 by early afternoon Tuesday, underperforming biotech peers as investors awaited updates on its blood-pressure drug lorundrostat. The stock remains up 183% over 52 weeks but is down 25% from its November high. Mineralys plans to file for FDA approval of lorundrostat by early 2026 and expects Phase 2 results in the first quarter of that year.
30 December 2025
··
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals shares dropped 4.2% to $107.85 in early afternoon trading Tuesday as biotech stocks broadly declined. Investors are awaiting an FDA decision on expanding Imcivree’s label, now expected by March 20, 2026. Board member Camille L. Bedrosian resigned effective immediately, according to an SEC filing. Major biotech ETFs fell over 1% while the broader market was flat.
30 December 2025
··
1 … 761 762 763 764 765 … 1,402

Stock Market Today

  • Investors Favor Google's AI Spending Over Meta Despite Both Raising Capex Guidance
    April 29, 2026, 10:00 PM EDT. Alphabet and Meta both reported strong first-quarter earnings, raising capital expenditure (capex) forecasts to fuel AI infrastructure. Alphabet's shares jumped 7% post-earnings, while Meta's dropped 7%, reflecting investor trust in Google's AI strategy. Alphabet's cloud division grew 63%, bolstering revenue by 20%, with a capex guidance raised to $180-$190 billion through 2026. Meta increased its capex forecast to $125-$145 billion, citing component costs and data center investments. Wall Street favors Alphabet's cloud-driven AI growth, contrasting with skepticism over Meta's AI investments tied primarily to advertising. Alphabet's stock is up 118% over the past year compared to Meta's 21%, underscoring the market's preference for sustainable AI revenue models.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop